Your browser doesn't support javascript.
loading
Anaphylaxis after Elosulfase A infusion: Omalizumab as coadjuvant for enzyme replacement therapy desensitization.
Arroabarren, Esozia; Aznal, Elena; Anda, Marta; Sanchez-Valverde, Felix.
Affiliation
  • Arroabarren E; Department of Allergy, Complejo Hospitalario de Navarra, Pamplona, Spain.
  • Aznal E; Department of Pediatrics, Complejo Hospitalario de Navarra, Pamplona, Spain.
  • Anda M; Department of Allergy, Complejo Hospitalario de Navarra, Pamplona, Spain.
  • Sanchez-Valverde F; Department of Pediatrics, Complejo Hospitalario de Navarra, Pamplona, Spain.
Pediatr Allergy Immunol ; 30(4): 491-494, 2019 06.
Article in En | MEDLINE | ID: mdl-30817035
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Chondroitinsulfatases / Desensitization, Immunologic / Drug Hypersensitivity / Enzyme Replacement Therapy / Omalizumab / Injection Site Reaction / Anaphylaxis Limits: Child, preschool / Humans / Male Language: En Journal: Pediatr Allergy Immunol Journal subject: ALERGIA E IMUNOLOGIA / PEDIATRIA Year: 2019 Document type: Article Affiliation country: España Country of publication: Reino Unido
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Chondroitinsulfatases / Desensitization, Immunologic / Drug Hypersensitivity / Enzyme Replacement Therapy / Omalizumab / Injection Site Reaction / Anaphylaxis Limits: Child, preschool / Humans / Male Language: En Journal: Pediatr Allergy Immunol Journal subject: ALERGIA E IMUNOLOGIA / PEDIATRIA Year: 2019 Document type: Article Affiliation country: España Country of publication: Reino Unido